White House Tightens Grip on NSF, Steering Billions Toward AI and Quantum

For the first time, National Science Foundation officials have publicly acknowledged that the Trump administration is reshaping the $9 billion agency around White House priorities—artificial intelligence and quantum information science. During a National Science Board briefing, acting director Brian Stone and Chief Management Officer Micah Cheatham described a shift away from NSF’s traditional community-driven funding model toward closer alignment with presidential directives. Cheatham defended “matrix management” as integrating outside input with administration goals, but critics see growing political control. NSF staffing has dropped 35% over the past year, largely through voluntary departures, and rotator appointments have been narrowed to AI- and quantum-focused roles. The agency has also halved targeted grant solicitations and launched “frontier initiatives” centered solely on AI and quantum, signaling a structural pivot in federal research funding priorities. (Science)

U.S. Flu Season Still Running Hot, With Pediatric Deaths Climbing
CDC’s latest FluView update shows influenza activity remains moderate to very high across much of the U.S., though several indicators are stabilizing or trending down. CIDRAP reports eight additional pediatric flu deaths in the most recent week, bringing the season total to 79, with about 90% of deaths (among those with known status) occurring in unvaccinated children. Outpatient visits for flu-like illness have been holding steady for weeks, lab positivity remains high (though down week over week), and influenza A still dominates even as influenza B gains ground. Genetic characterization suggests many circulating A(H3N2) viruses fall in a subclade with mutations that can help evade immunity from this season’s vaccine formula. (CIDRAP)

Measles Passes 1,000 U.S. Cases in Early 2026, Putting “Elimination” Status at Risk
Scientific American reports the U.S. has surpassed 1,000 confirmed measles cases in 2026—1,136 as of February 26—an unusually fast acceleration for a vaccine-preventable disease. Experts quoted in the piece emphasize that measles’ resurgence reflects falling vaccination rates rather than any new viral trick. The article notes that official counts likely understate true spread, and that most confirmed infections are linked to outbreaks across more than a dozen states, indicating sustained local transmission. Public health officials warn that if a chain of local transmission continues for more than 12 months, the U.S. risks losing its measles-elimination status (achieved in 2000). The piece frames the moment as a preventable crisis with community-wide consequences for people who cannot be vaccinated. (Scientific American)

SNAP Restrictions on Sugary Drinks and Ultra-Processed Foods Move From Idea to Pilot Policy
A new JAMA Viewpoint argues that, whatever else is controversial about “Make America Healthy Again” politics, targeting ultra-processed foods is directionally aligned with a large evidence base linking sugar-sweetened beverages and other unhealthy UPFs to obesity, diabetes, cardiovascular disease, and some cancers. The authors report that 18 states are beginning efforts to restrict sugar-sweetened beverages and other UPFs from SNAP via USDA waivers, implemented through retailer point-of-sale systems. They emphasize that these pilots will require evaluation—though approaches may vary—and situate the push in the context of diet-related disease burdens that disproportionately affect low-income communities. The piece treats this as a serious policy experiment with big equity and implementation questions, not a symbolic gesture. (JAMA Network)

ChatGPT “Triage Advice” Put Under a Structured Stress Test in Nature Medicine
A Nature Medicine research article reports a structured evaluation of “ChatGPT Health” for triage recommendations using clinical vignettes benchmarked against evidence-based guidelines. The journal notes the manuscript is provided in an early (unedited) form for rapid access, and includes extensive supplementary material tying gold-standard triage assignments to guidelines across many professional societies. The paper’s core point is not that an LLM replaces clinicians, but that triage quality can be measured systematically—and that performance must be judged against real clinical standards, including safety, escalation thresholds, and consistency. The work lands amid ongoing debates about consumer-facing symptom checkers, clinician workflow tools, and how to audit algorithmic medical advice for bias, reliability, and harm. (Details like model behavior patterns and error types are discussed within the article’s methods/results.) (Nature)

Shingles Vaccine Linked to Lower Dementia Risk in a Large Matched Cohort Study
A Nature Communications paper reports a retrospective matched cohort study of Kaiser Permanente Southern California members aged 65+ that found two doses of recombinant zoster vaccine (RZV), given 4 weeks to 6 months apart, were associated with a substantially lower risk of dementia compared with matched unvaccinated individuals. The study uses Cox regression with inverse probability weighting and includes roughly 65,800 vaccinated people matched to 263,200 unvaccinated controls. The authors report an adjusted hazard ratio suggesting markedly lower dementia risk (with effects broadly consistent across age and racial/ethnic groups, and stronger in females). To probe “healthy vaccinee” bias, they compare against Tdap-vaccinated individuals; the association attenuates but remains statistically significant. The paper concludes more research is needed on mechanisms, but suggests potential benefits beyond shingles prevention. (Nature)

EMA Backs a Single-Dose Oral Treatment for Sleeping Sickness
The European Medicines Agency reports its human medicines committee (CHMP) adopted a positive scientific opinion for Acoziborole Winthrop to treat human African trypanosomiasis (sleeping sickness) caused by Trypanosoma brucei gambiense. EMA frames this as a major simplification: a single-dose oral option designed for use outside the EU, assessed under the EU-M4all program aimed at improving access to essential medicines in low- and middle-income countries. The announcement highlights the public-health importance of easier treatment logistics for both first- and second-stage disease, where diagnosis and care can be difficult in remote settings. In practical terms, a treatment that reduces dependence on complex, hospital-based regimens could help accelerate control and elimination efforts—if paired with strong surveillance and delivery capacity in endemic regions. (European Medicines Agency (EMA))

The CDC’s Leadership Instability Becomes a Public-Health Risk of Its Own
WIRED describes ongoing turmoil at the CDC, arguing that rapid turnover at the top—paired with major staffing losses—creates an institutional fragility that can undermine preparedness and response. The piece reports that after the departure of acting director Jim O’Neill, NIH director Jay Bhattacharya is temporarily leading both agencies, and notes the broader backdrop: repeated leadership changes and a significant reduction in CDC staff tied to HHS actions under Secretary Robert F. Kennedy Jr. The article situates the leadership whiplash as more than inside-baseball bureaucracy: when chain-of-command, policy direction, and expert capacity are unstable, everything from outbreak response to vaccine guidance to public trust can suffer. It’s a systems story—about governance as a health variable. (WIRED)

Breathing Slower—With Longer Exhales—May Lower Blood Pressure for Some People
Harvard Health explains how deliberate slow breathing (often defined as ~6–10 breaths per minute with prolonged exhalation) can activate vagal pathways tied to the body’s “rest and digest” response. The piece cites expert commentary suggesting that practicing slow, deep breathing for about 15 minutes daily may reduce systolic blood pressure in some people—potentially by up to 10 points for certain individuals with hypertension. It also summarizes evidence from a review in Frontiers in Physiology that found most included studies reported reductions in systolic and diastolic blood pressure, while noting big variation in protocols (type, duration, frequency), making it hard to prescribe one universal routine. The article offers practical guidance and frames breathing as a low-risk adjunct—especially relevant for stress-linked blood pressure patterns. (Harvard Health)

After a Seizure, the Brain May “Consolidate” Seizure Pathways During Sleep
Mayo Clinic reports research suggesting the brain may unintentionally reinforce epilepsy by treating seizures like salient memories that get consolidated during deep sleep. In recordings from implanted devices in 11 people with epilepsy, researchers observed that after seizures the brain entered a prolonged, intensified non-REM deep-sleep state with features associated with memory consolidation—particularly in regions where seizures originate. The team describes this as “seizure-related consolidation,” proposing a vicious cycle: seizures trigger post-seizure sleep dynamics that strengthen the networks that generate future seizures. The practical implication is a new therapeutic window—hours after a seizure and the subsequent night—when targeted interventions (including adaptive, closed-loop neuromodulation approaches) might disrupt reinforcement and slow progression. It’s a compelling reframing of sleep from symptom to mechanism. (Mayo Clinic News Network)

EHR “Early-Warning” Patterns: Dozens of Conditions Often Precede Alzheimer’s Diagnosis
MedicalXpress covers a Vanderbilt-led study that mined two large electronic health record datasets to identify medical conditions that appear more frequently in the decade before an Alzheimer’s disease diagnosis. Using MarketScan (claims data) as a discovery cohort and Vanderbilt’s EHR system for validation, researchers compared tens of thousands of Alzheimer’s cases against matched controls and found more than 70 conditions that replicated across both databases. These were dominated by mental health signals (including depression and severe neuropsychiatric symptoms), neurologic and sleep-related conditions (insomnia, hypersomnia, sleep apnea), cardiovascular/circulatory conditions (hypertension, cerebral atherosclerosis/ischemia), and endocrine/metabolic conditions (type 2 diabetes). The authors stress association isn’t causation, but argue this inventory could inform earlier risk recognition and prevention-focused research—especially if midlife interventions can delay onset. (Medical Xpress)

SBIR Funding Lapse Leaves Startups—and Rare Disease Research—in Limbo

A congressional lapse in reauthorizing the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs has thrown federally backed startups into uncertainty. The programs, long bipartisan and responsible for launching firms like Qualcomm and Illumina, require agencies with large R&D budgets to dedicate a portion to early-stage innovation grants. But after disagreements over reforms—including curbing “grant mills” and tightening foreign participation rules—Congress failed to renew authorization in September 2025, halting new awards. Companies like Phoenix Nest, developing a gene therapy for Sanfilippo syndrome, and CytexOrtho, advancing bioabsorbable hip implants, have paused studies and face potential layoffs. Although senators reportedly reached a tentative deal, entrepreneurs warn the disruption has already chilled investment, stalled clinical trials, and destabilized a critical pipeline linking academic discoveries to commercial therapies. (Science)